by Luis Castaneda | Nov 30, 2023 | Featured, Health & Science
WASHINGTON – Efforts to build trust between House Republicans and the new director of the Centers for Disease Control and Prevention, Dr. Mandy Cohen, fell short Thursday morning as GOP members continued to use the agency as a lightning rod for their criticism of the...
by Luis Castaneda | Nov 9, 2023 | Featured, Health & Science, Politics
WASHINGTON – Christine Huberty provides legal assistance to those facing health care coverage denial. On May 25, one of her clients, Jim, was hospitalized for pneumonia. He had been receiving chemotherapy treatment and had a history of chronic obstructive pulmonary...
by Luis Castaneda | Nov 9, 2023 | Featured, National Security
WASHINGTON — As the Israeli-Hamas war escalates in the Middle East, protesters and House progressives have called for a cease-fire. On Saturday, Washington D.C. saw ‘the largest pro-Palestinian demonstration in U.S. history,’ according to the International People’s...
by Luis Castaneda | Oct 19, 2023 | Featured, Health & Science
WASHINGTON – Dr. Gerald W. Parker, chair of the National Science Advisory Board for Biosecurity (NSABB), told House lawmakers on Wednesday that research laboratories worldwide handling dangerous pathogens continue to pose a credible threat in producing future...
by Luis Castaneda | Oct 17, 2023 | Featured, Health & Science
WASHINGTON — The Novavax COVID-19 vaccine is now available after receiving approval from the CDC and FDA last week. This year, the COVID-19 shots will be commercialized, selling on the market between $120-$130. 92.3% of Americans, according to the CDC, are currently...
by Luis Castaneda | Oct 5, 2023 | Featured, Health & Science
WASHINGTON – The Biden administration announced Tuesday that all 10 drug manufacturers it selected for the Medicare Drug Price Negotiations Program have agreed to participate. The drugs selected for the negotiations range from blood thinners like Eliquis and Xarelto;...
